简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2019-03-05 10:00 uLab Systems Partners with MEM Dental to Expand Orthodontic Offering
2019-03-01 17:30 Global Ingredients Brand, NZMP, Picks Its Top 5 Consumer Trends for 2019
2019-03-01 13:44 JIUN to Release SonicDICOM PACS Cloud, a Cloud-Based Medical Image Management System, in March
2019-02-28 14:03 ndian President Presents Award to The Nippon Foundation Chairman Yohei Sasakawa in Recognition of Years of Work to Eliminate Leprosy
2019-02-27 13:45 Boehringer Ingelheim and GNA Biosolutions partner on emergency veterinary diagnostics development
2019-02-26 16:11 LMD’s Smartphone-Integrated e-Checkup™ System Makes Medically-Accurate Personal Health Monitoring a Reality
2019-02-26 13:18 Oral-B’s NEW AI-Brush Knows More About Brushing Styles Than Anyone on The Planet
2019-02-26 13:13 New Case Series Investigates the Combined Use of Masimo SedLine® Brain Function Monitoring and O3® Regional Oximetry During Cardiac Surgery
2019-02-25 09:48 Mundipharma EDO GmbH: US FDA grants Orphan Drug Designation for etoposide toniribate in relapsed/refractory biliary tract cancer
2019-02-22 13:31 KCI Launches ABTHERA™ Therapy in Japan
2019-02-21 16:49 ResMed and Fisher & Paykel Healthcare Announce Settlement of Global Patent Infringement Litigation
2019-02-20 18:35 Owlstone Medical Partners with Shanghai Renji Hospital to Pioneer Breath Biopsy Lung Cancer Trial in China
2019-02-20 13:31 Saudi Arabia Ministry of Health and Masimo Announce Automation of National Neonatal CCHD Screening Process Using Masimo Technology
2019-02-18 09:39 Minomic Signs Agreement with US Pathology Laboratory
2019-02-15 09:29 Boehringer Ingelheim and Lilly’s CAROLINA® cardiovascular outcome trial for Trajenta® meets primary endpoint of non-inferiority compared to glimepiride
2019-02-14 13:48 SpeeDx Develops Multiplex Test for Respiratory Viruses
2019-02-14 10:05 European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD, the First New Treatment in Decades for Adults with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma
2019-02-13 10:27 Samsung Bioepis and C-Bridge Capital to Develop and Commercialize Next-Generation Biosimilars in China
2019-02-12 16:24 H.I.G. Capital Completes Acquisition of Taconic Biosciences
2019-02-12 14:07 Takeda Announces Results from First-of-Its-Kind Phase IIIb/IV Trial PROPEL – a Randomized PK-Guided Prophylaxis Study Evaluating Higher Factor VIII Levels in Hemophilia A– at EAHAD 2019

Business Wire Weibo

Press Releases

Latest Releases